CIK 0001828673 · <br>Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825024477
- Phone
- 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-22 | Byam Rebecca Chief Financial Officer | Purchase | +33,450 | $1.53 | $51K | 395,152 |
| 2022-11-02 | Byam Rebecca Chief Financial Officer | Option exercise | +33,750 | $0.14 | $5K | 361,702 |
| 2022-11-02 | Byam Rebecca Chief Financial Officer | Option exercise · Stock Option Grant (Right to Buy) | −33,750 | 47,249 | ||
| 2022-09-14 | Byam Rebecca Chief Financial Officer | Purchase | +15,000 | $2.58 | $39K | 327,952 |
| 2022-09-13 | Byam Rebecca Chief Financial Officer | Purchase | +15,000 | $2.58 | $39K | 312,952 |
| 2022-09-12 | Byam Rebecca Chief Financial Officer | Purchase | +15,000 | $2.65 | $40K | 297,952 |
| 2022-09-09 | Wong Hing C Chief Executive Officer | Purchase | +6,000 | $2.70 | $16K | 15,306,468 |
| 2022-09-08 | Wong Hing C Chief Executive Officer | Purchase | +4,000 | $2.67 | $11K | 15,300,468 |
| 2022-09-07 | Wong Hing C Chief Executive Officer | Purchase | +6,000 | $2.58 | $15K | 15,296,468 |
| 2022-09-02 | Wong Hing C Chief Executive Officer | Purchase | +4,000 | $2.55 | $10K | 15,290,468 |
| 2022-08-31 | Byam Rebecca Chief Financial Officer | Purchase | +10,000 | $2.56 | $26K | 282,952 |
| 2022-08-30 | Byam Rebecca Chief Financial Officer | Purchase | +7,200 | $2.55 | $18K | 272,952 |
| 2022-08-29 | Byam Rebecca Chief Financial Officer | Purchase | +10,000 | $2.57 | $26K | 265,752 |
| 2022-08-26 | Byam Rebecca Chief Financial Officer | Purchase | +10,000 | $2.54 | $25K | 255,752 |
| 2022-08-25 | Byam Rebecca Chief Financial Officer | Purchase | +40,300 | $2.59 | $105K | 245,752 |
| 2022-08-24 | Byam Rebecca Chief Financial Officer | Purchase | +50,000 | $2.50 | $125K | 205,452 |
| 2022-06-15 | Winer Gary M Director | Grant or award · Stock Option (Right to Buy) | +41,841 | 41,841 | ||
| 2022-06-15 | Greene Rick S. Director | Grant or award · Stock Option (Right to Buy) | +41,841 | 41,841 | ||
| 2022-06-15 | Giles Lisa M. Director | Grant or award · Stock Option (Right to Buy) | +41,841 | 41,841 | ||
| 2022-06-15 | GARRETT SCOTT T Director | Grant or award · Stock Option (Right to Buy) | +41,841 | 41,841 |
Page 5 of 9 · 164 trades